| Newly Diagnosed Glioblastoma: A Review on Clinical Management |
24 |
| Carboplatin/Paclitaxel Induction in Ovarian Cancer: The Finer Points |
14 |
| Fear of Cancer Recurrence: A Practical Guide for Clinicians |
13 |
| CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor-Positive Advanced Breast Cancer? |
13 |
| Immune Checkpoint Inhibitor Therapy in Patients With Autoimmune Disease |
8 |
| Primary Central Nervous System Lymphoma PART 1: Epidemiology, Diagnosis, Staging, and Prognosis |
8 |
| Obese Breast Cancer Patients and Survivors: Management Considerations |
7 |
| Role of Temozolomide in the Treatment of Cancers Involving the Central Nervous System |
7 |
| The Adjuvant Treatment of Stage III Colon Cancer: Might Less Be More? |
7 |
| Artificial Intelligence in Oncology: Current Applications and Future Directions |
7 |
| Herb-Drug Interactions in Cancer Care |
7 |
| Using PARP Inhibitors in Advanced Ovarian Cancer |
6 |
| Combination Controversies: Checkpoint Inhibition Alone or in Combination for the Treatment of Melanoma? |
5 |
| State of Cancer Research Around the Globe |
5 |
| Gonadotropin-Releasing Hormone Antagonists in Prostate Cancer |
5 |
| Prognostic Value of Low Tumor Burden in Patients With Melanoma |
5 |
| DLBCL Cell of Origin: What Role Should It Play in Care Today? |
4 |
| What to Do When Anti-PD-1 Therapy Fails in Patients With Melanoma |
4 |
| Immunotherapy for Prostate Cancer: Where Do We Go From Here? PART 2: Checkpoint Inhibitors, Immunotherapy Combinations, Tumor Microenvironment Modulation, and Cellular Therapies |
4 |
| Suicide in Patients With Cancer: Identifying the Risk Factors |
4 |
| Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice PART 2: ENKTL, EATL, Indolent T-Cell LDP of the GI Tract, ATLL, and Hepatosplenic T-Cell Lymphoma |
4 |
| Improving Childhood Cancer Survivor Care Through Web-Based Platforms |
3 |
| Navigating Cancer Pain Management in the Midst of the Opioid Epidemic |
3 |
| New Developments in Neoadjuvant Therapy for Lung Cancer |
3 |
| Current Strategies for the Management of Locoregional Breast Cancer Recurrence |
3 |
| Immunotherapy for Prostate Cancer: Where Do We Go From Here? PART 1: Prostate Cancer Vaccines |
3 |
| Current and Future Landscape of Immune Checkpoint Inhibitors in Urothelial Cancer |
3 |
| Peripheral T-Cell Lymphomas: Incorporating New Developments in Diagnostics, Prognostication, and Treatment Into Clinical Practice |
3 |
| Integrating Immunotherapy Into Colorectal Cancer Care |
3 |
| Understanding the Benefits of Acupuncture Treatment for Cancer Pain Management |
3 |
| Inadequate Awareness of and Participation in Cancer Clinical Trials in the Community Oncology Setting |
3 |
| Complications of Androgen Deprivation Therapy in Men With Prostate Cancer |
3 |
| The Diagnosis and Management of Retroperitoneal Sarcoma |
2 |
| Implications of Mutation Profiling in Myeloid Malignancies PART 1: Myelodysplastic Syndromes and Acute Myeloid Leukemia |
2 |
| How to Decide Which DLBCL Patients Should Receive CNS Prophylaxis |
2 |
| Primary Central Nervous System Lymphoma part 2: Modern Therapeutic Management and Future Directions |
2 |
| Systemic Treatment Options for Brain Metastases from Non-Small-Cell Lung Cancer |
2 |
| Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non CNS Malignancies |
2 |
| Effective Palliative Care: What Is Involved? |
2 |
| Secondary Prevention Strategies for Nonmelanoma Skin Cancer |
2 |
| Acute Kidney Injury in Patients With Cancer |
2 |
| Harnessing the Immunomodulatory Effects of Radiation Therapy |
2 |
| Managing Nausea and Vomiting in Patients With Cancer: What Works |
2 |
| Improving Adherence to Endocrine Therapy in Women With HR-Positive Breast Cancer |
1 |
| The Use of Surgery and Radiotherapy as Treatment of Regional Nodes in Breast Cancer Patients |
1 |
| Wedding Rigorous Scientific Methodology and Ancient Herbal Wisdom to Benefit Cancer Patients: The Development of PHY906 |
1 |
| Managing Psychosocial Distress: Lessons Learned in Optimizing Screening Program Implementation |
1 |
| When Surgery Is Not an Option in Renal Cell Carcinoma: The Evolving Role of Stereotactic Body Radiation Therapy |
1 |
| Sharing Serious News With Cancer Patients: Strategies That Can Help |
1 |
| Using Genomic Sequencing to Improve Management in Melanoma |
1 |
